Home / Share Price Target / Venusrem
Venus Remedies Share Price Target 2024, 2025, 2026 to 2039 With Charts
Venus Remedies Limited | |||
 | Symbol: VENUSREM | ||
| Price: ₹302.64 | |||
| Exchange: NSE | |||
| Healthcare -> Drug Manufacturers—Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: Venus Remedies Brief Company Overview
- 1.1: Venus Remedies Limited: Pharmaceuticals with a Global Reach
- 1.2: Venus Remedies Financial Performance
- 1.2.1: Is Venus Remedies A Good Buy For Long Term?
- 2: Approach 1: Technical Analysis Paired With Price Action
- 2.1: Venus Remedies Share Price Target For 2024
- 2.1.1: Venus Remedies Share Price Target Table For 2024
- 2.1.2: Summary: Venus Remedies Share Price Prediction For 2024
- 2.2: Venus Remedies Share Price Target For 2025
- 2.2.1: Venus Remedies Share Price Target Table For 2025
- 2.2.2: Summary: Venus Remedies Share Price Prediction For 2025
- 3: Approach 2: Machine Learning By Studying Historical Prices
- 3.1: Venus Remedies Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 3.2: Venus Remedies Share Price Target Table From 2024, 2025, 2026 to 2039
- 4: Venus Remedies Past Performance
Venus Remedies Brief Company Overview
Venus Remedies Limited: Pharmaceuticals with a Global Reach
Venus Remedies Limited, established in 1989, is a leading pharmaceutical company headquartered in India. Venus Remedies is dedicated to developing, manufacturing, and marketing innovative pharmaceutical products that cater to various therapeutic areas including analgesics, anti-diabetics, antibiotics, and oncology.
Broad Product Range: Venus Remedies boasts a comprehensive portfolio of pharmaceuticals, including:
- Anti-infectives
- Anticoagulants
- Anti-diabetic drugs
- Antibiotics
- Antifungals
- Antivirals
International Presence: Venus Remedies has a global presence, with its products available in over 70 countries.
Advertisement
Venus Remedies Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 408.03 Crore | Market valuation of Venus Remedies's shares. |
| Revenue (TTM) | 561.92 Crore | Total revenue generated by Venus Remedies over the past twelve months. |
| Net Income (TTM) | +29.02 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | 3.83% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 5.16% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) | +22.7% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) | +108.2% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio | 8.86 | Company's total debt divided by total shareholder equity. |
| Total Debt | 41.74 Crore | Sum of Venus Remedies's current & long-term financial obligations. |
| Total Cash | 70.75 Crore | Total amount of liquid funds available to Venus Remedies. |
| Beta | 1.07 | Beta is greater than 1 indicating that the Venus Remedies's price is more volatile than the market. |
Is Venus Remedies A Good Buy For Long Term?
Venus Remedies has experienced an impressive 108.2% increase in earnings and a 22.7% jump in revenue. However, the company's debt remains high at Rs. 41.74 crore. With a profit margin of 5.16%, the company's profitability is moderate. While the stock has generated substantial returns in the past, its recent performance has been volatile. Overall, Venus Remedies appears to be a moderately risky investment with the potential for long-term growth.
To predict the Venus Remedies's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Venus Remedies Share Price Target For 2024
The line chart displays the monthly closing prices of Venus Remedies with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Venus Remedies shares in 2024, see the table below.
Advertisement
Venus Remedies Share Price Target Table For 2024
| Venus Remedies's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 313.95 (+3.73%) | Price Action: Jul 2006 High |
| 2024 Target 2 | 309.50 (+2.26%) | Price Action: Jun 2005 High |
| 2024 Target 1 | 306.04 (+1.12%) | Fibonacci Extension Level 100% |
| Current Price | 302.64 | Venus Remedies's 1 share price as of Thu 14 Nov 2024 |
| Stop Loss 1 | 301.00 (-0.55%) | Price Action: May 2024 Low |
| Stop Loss 2 | 297.17 (-1.81%) | Fibonacci Retracement Level 50% |
| Stop Loss 3 | 294.00 (-2.86%) | Price Action: Jun 2021 Low |
Summary: Venus Remedies Share Price Prediction For 2024
In summary, Venus Remedies has declined by ₹-103.61, recording a notable -25.50% decrease from 1st January 2024 to 14 Nov 2024. Despite the setback, our analysis of Venus Remedies for 2024 predicts an additional rise of 1.12% to 3.73% by the end of 2024 with three potential targets T1: 306.04, T2: 309.50, T3: 313.95. Stop Loss at SL1: 301.00, SL2: 297.17, SL3: 294.00.
Venus Remedies has a 52-week high of ₹430.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹281.10, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Venus Remedies.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Venus Remedies Share Price Target For 2025
The line chart displays the monthly closing prices of Venus Remedies with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Venus Remedies shares in 2025, see the table below.
Advertisement
Venus Remedies Share Price Target Table For 2025
| Venus Remedies's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 423.69 (+39.99%) | Price Action: Chart |
| 2025 Target 2 | 415.79 (+37.38%) | Price Action: Chart |
| 2025 Target 1 | 411.67 (+36.02%) | Custom Fibonacci Extension Lvl 64.9% |
| Current Price | 302.64 | Venus Remedies's 1 share price as of Thu 14 Nov 2024 |
| Stop Loss 1 | 277.45 (-8.33%) | Price Action: Dec 2010 High |
| Stop Loss 2 | 274.00 (-9.47%) | Price Action: Apr 2013 High |
| Stop Loss 3 | 270.00 (-10.79%) | Price Action: Jun 2009 High |
Summary: Venus Remedies Share Price Prediction For 2025
In summary, Venus Remedies has declined by ₹-103.61, recording a notable -25.50% decrease from 1st January 2024 to 14 Nov 2024. Despite the setback, our analysis of Venus Remedies for 2025 predicts an additional rise of 36.02% to 39.99% by the end of 2025 with three potential targets T1: 411.67, T2: 415.79, T3: 423.69. Stop Loss at SL1: 277.45, SL2: 274.00, SL3: 270.00.
Venus Remedies has a All-Time high of ₹639.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹281.10, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Venus Remedies, we have created a specific page for that check here: Venus Remedies Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Venus Remedies Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Venus Remedies share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 3.4% over the next 15 years.
For complete year by year Venus Remedies long term share price target from 2024, 2025 to 2039 check the below table.
Venus Remedies Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | Venus Remedies Target | YoY Change % |
|---|---|---|
| 2024 | ₹302.64 | [Current Price] |
| 2024 | ₹371.61 | 22.78% |
| 2025 | ₹345.8 | -6.95% |
| 2026 | ₹390.01 | 12.78% |
| 2027 | ₹460.76 | 18.14% |
| 2028 | ₹511.3 | 10.96% |
| 2029 | ₹462.29 | -9.59% |
| 2030 | ₹426.25 | -7.8% |
| 2031 | ₹476.71 | 11.83% |
| 2032 | ₹558.83 | 17.22% |
| 2033 | ₹615.67 | 10.17% |
| 2034 | ₹552.96 | -10.19% |
| 2035 | ₹506.7 | -8.37% |
| 2036 | ₹563.41 | 11.19% |
| 2037 | ₹656.9 | 16.59% |
| 2038 | ₹720.07 | 9.61% |
| 2039 | ₹593.55 | -17.57% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Venus Remedies Past Performance
- In 1995, Venus Remedies opening price was ₹11.5
- As of Thu 14 Nov 2024 the price stands at ₹302.64.
- This represents a Compound Annual Growth Rate (CAGR) of 11.52%.
- In 29 years, an investment of 10,000 would have become ₹2.63 Lakh.
As we wrap up, we hope you like our study on Venus Remedies share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
- Venus Remedies Share Price History
- Venus Remedies Price Target Tomorrow
- Venus Remedies Dividend History
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
